advanced squamous cell lung cancer
Showing 1 - 25 of >10,000
Advanced Lung Squamous Cell Carcinoma Trial in Chengdu (low-dose radiation therapy and stereotactic body radiation therapy,
Not yet recruiting
- Advanced Lung Squamous Cell Carcinoma
- low-dose radiation therapy and stereotactic body radiation therapy
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Nov 13, 2023
Advanced Squamous Non Small Cell Lung Cancer Trial (AK112, Carboplatin, Paxlitaxel, Tislelizumab, Carboplatin, Paxlitaxel)
Not yet recruiting
- Advanced Squamous Non Small Cell Lung Cancer
- AK112, Carboplatin, Paxlitaxel
- Tislelizumab, Carboplatin, Paxlitaxel
- (no location specified)
Apr 21, 2023
Advanced Squamous Non-Small-Cell Lung Cancer Trial (Trilaciclib, Carboplatin, Paclitaxel)
Not yet recruiting
- Advanced Squamous Non-Small-Cell Lung Cancer
- Trilaciclib
- +3 more
- (no location specified)
Jun 11, 2023
Advanced or Metastatic Squamous NSCLC Trial in Sydney (HMBD-001, Docetaxel, Cetuximab)
Not yet recruiting
- Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
- HMBD-001
- +2 more
-
Sydney, New South Wales, AustraliaGenesisCare North Shore
Jun 20, 2023
NSCLC Trial in Wuhan (Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel)
Recruiting
- Non-small Cell Lung Cancer
- Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel
-
Wuhan, Hubei, ChinaUnion hospital
Feb 20, 2023
Advanced Non-squamous Non-small-cell Lung Cancer, Recurrent Non-Squamous NSCLC, Metastatic Non-squamous Non Small Cell Lung
Not yet recruiting
- Advanced Non-squamous Non-small-cell Lung Cancer
- +2 more
- pembrolizumab
- +2 more
-
Beijing, Beijing, ChinaPeking University First Hospital Ethics Committee
Sep 10, 2023
Lung Cancer, Non-squamous, Non-small Cell Trial (zongertinib, pembrolizumab, cisplatin)
Not yet recruiting
- Lung Cancer, Non-squamous, Non-small Cell
- zongertinib
- +4 more
- (no location specified)
Nov 22, 2023
Advanced Non-squamous Non-Small-Cell Lung Cancer Trial in Jinan (Sintilimab)
Recruiting
- Advanced Non-squamous Non-Small-Cell Lung Cancer
-
Jinan, Shandong, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Dec 4, 2022
Non Squamous Non Small Cell Lung Cancer Trial in Korea, Republic of (Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin)
Not yet recruiting
- Non Squamous Non Small Cell Lung Cancer
- Camrelizumab (SHR-1210), Pemetrexed, and Carboplatin
-
Anam, Korea, Republic of
- +7 more
May 1, 2023
Non Small Cell Lung Cancer, Immune Checkpoint Inhibitor, EGFR Exon 21 Mutation Trial in Peking (Pembrolizumab, pemetrexed,
Not yet recruiting
- Non Small Cell Lung Cancer
- +2 more
- Pembrolizumab, pemetrexed, platinum
- Osimertinib
-
Peking, ChinaPeking Union Medical College Hospital
Nov 16, 2023
Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma Trial (XNW5004, Pembrolizumab 25 mg/mL Solution for
Not yet recruiting
- Carcinoma
- +7 more
- XNW5004
- Pembrolizumab 25 mg/mL Solution for Injection
- (no location specified)
Aug 31, 2023
Advanced Non-Small Cell Squamous Lung Cancer, Radiotherapy, Immunotherapy Trial in Wuhan (CTV omitted or delineated)
Not yet recruiting
- Advanced Non-Small Cell Squamous Lung Cancer
- +2 more
- CTV omitted or delineated
-
Wuhan, Hubei, ChinaHubei Cancer Hospital
Sep 7, 2023
Non-squamous Non-small-cell Lung Cancer Trial in Hangzhou (Tusamitamab ravtansine+Sintilimab+Carboplatin or
Not yet recruiting
- Non-squamous Non-small-cell Lung Cancer
- Tusamitamab ravtansine+Sintilimab+Carboplatin or Cisplatin+Pemetrexed
- +2 more
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
May 5, 2023
Cervical Cancer, Head and Neck Squamous Cell Carcinoma, NSCLC Trial in Boston, Saint Louis (ITIL-168)
Withdrawn
- Cervical Cancer
- +2 more
- ITIL-168
- (no location specified)
Dec 16, 2022
Non-squamous NSCLC Trial in Nanjing (paclitaxel polymeric micelles for injection)
Not yet recruiting
- Non-squamous NSCLC
- paclitaxel polymeric micelles for injection
-
Nanjing, Jiangsu, China
- +1 more
Mar 13, 2023
NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in Lexington (Immune checkpoint inhibitor, Radiation Therapy)
Recruiting
- Non-small Cell Lung Cancer
- Squamous Cell Carcinoma of the Head and Neck
- Immune checkpoint inhibitor
- Radiation Therapy
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
Nov 10, 2022
Advanced Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma Trial in
Recruiting
- Advanced Head and Neck Squamous Cell Carcinoma
- +14 more
- Laboratory Biomarker Analysis
- +3 more
-
Indianapolis, Indiana
- +4 more
Aug 19, 2022
Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer Trial in Boston (Palbociclib, Gedatolisib)
Recruiting
- Lung Cancer Squamous Cell
- +3 more
-
Boston, Massachusetts
- +2 more
Jan 9, 2023
NSCLC Trial in Guangzhou (Surufatinib,Toripalimab,Pemetrexed,Carboplatin/Cisplatin)
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Guangzhou, Guang Dong, ChinaSun Yat-sen University Cancer Center
Nov 3, 2022
Advanced Squamous Non-Small Cell Lung Carcinoma Trial in Beijing, Tianjin, Kunming (TQB2450, Anlotinib HCl capsule, Tislelizumab
Not yet recruiting
- Advanced Squamous Non-Small Cell Lung Carcinoma
- TQB2450
- +2 more
-
Beijing, Beijing, China
- +3 more
Feb 12, 2023